Consolidated Edison reports second-quarter results on August 6 against a backdrop of softening price action and a Street that has tilted measurably bearish on valuation.
The stock shed 3.7% over the past week to close at $108.85, a move that broadly tracks the utility sector — closest peers WEC, CNP, and DTE all fell between 5% and 5.7% over the same stretch, suggesting sector-wide rate-sensitivity rather than a company-specific concern. Short interest, at roughly 3.9% of free float, is not extreme but has ticked up about 3.4% over the week even as it remains well below its late-June peak above 4.4%. The borrow market is not generating meaningful pressure: availability is exceptionally loose at nearly 3,000%, with cost to borrow having eased 17% on the week to just 0.38%. The options market tells a similarly calm story — the put/call ratio edged up to 0.40 on Friday, modestly above its 20-day average of 0.39, but well within one standard deviation of normal and nowhere near the 52-week defensive extreme of 0.86. Positioning looks neutral rather than charged ahead of the print.
The central tension heading into earnings is a valuation one. ED trades at roughly 17.2x earnings, and the mean Street price target of $111.85 implies only about 3% upside from current levels — a thin margin for a regulated utility carrying what is effectively a consensus bearish rating. Keybanc trimmed its target to $94 on July 23, maintaining an Underweight, while Morgan Stanley and Barclays both hold Underweight ratings with targets at $105 and $107 respectively — all sitting below the current share price. The bull case rests on Q1's earnings beat, a constructive multi-year rate plan taking shape, and a dividend score in the 91st percentile of the universe, which anchors demand from income-oriented investors. Bears counter with regulatory uncertainty, capital expenditure risk, and rate sensitivity — and notably, Mizuho downgraded the stock to Neutral in early June, reducing the camp of active supporters. The analyst recommendation differential ranks in just the 4th percentile across the universe, a blunt signal that the Street views the stock as fully priced at best.
The CFO sold approximately $955,000 worth of shares at $112.09 on July 8, the most recent insider transaction on record. That sale came at a price above the current level, and while the significance score is low and no buying has appeared in the 90-day window, the direction of insider flow does not contradict the cautious analyst tone.
The August 6 print will test whether Q2 earnings and any update on the three-year rate plan give the bulls sufficient evidence to argue the stock deserves a re-rating above the price targets currently set by its most prominent bearish analysts.
See the live data behind this article on ORTEX.
Open ED on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
